Dauntless Investment Group, LLC 13D and 13G filings for OKYO Pharma Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-18 2:35 pm Purchase |
2025-03-12 | 13G | OKYO Pharma Limited OKYO |
Dauntless Investment Group, LLC | 1,999,380 5.900% |
1,999,380 (New Position) |
Filing |